In fact, prospective studies are currently being conducted to examine the association of antihyperglycemic drugs such as sodium-glucose cotransporter 2 inhibitors or dipeptidyl peptidase-4 inhibitor with GLS in T2DM patients [39–42]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.